Axa S.A. Increases Stock Position in Dolby Laboratories, Inc. (NYSE:DLB)

AXA S.A. increased its stake in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) by 574.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 76,358 shares of the electronics maker's stock after purchasing an additional 65,040 shares during the period. AXA S.A. owned approximately 0.08% of Dolby Laboratories worth $5,964,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Fifth Third Bancorp lifted its stake in Dolby Laboratories by 82.7% in the 4th quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker's stock valued at $28,000 after purchasing an additional 163 shares during the last quarter. Nisa Investment Advisors LLC lifted its position in shares of Dolby Laboratories by 436.2% in the fourth quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker's stock valued at $29,000 after buying an additional 301 shares during the last quarter. Mather Group LLC. boosted its stake in shares of Dolby Laboratories by 36.8% during the 4th quarter. Mather Group LLC. now owns 528 shares of the electronics maker's stock worth $41,000 after acquiring an additional 142 shares during the period. Headlands Technologies LLC acquired a new stake in Dolby Laboratories during the 4th quarter valued at $57,000. Finally, GAMMA Investing LLC boosted its position in Dolby Laboratories by 207.5% during the fourth quarter. GAMMA Investing LLC now owns 778 shares of the electronics maker's stock worth $61,000 after purchasing an additional 525 shares during the period. Institutional investors and hedge funds own 58.56% of the company's stock.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, CMO Todd Pendleton sold 18,121 shares of the firm's stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $83.75, for a total value of $1,517,633.75. Following the sale, the chief marketing officer now owns 37,290 shares in the company, valued at $3,123,037.50. This trade represents a 32.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP John D. Couling sold 675 shares of Dolby Laboratories stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $75.04, for a total transaction of $50,652.00. Following the sale, the senior vice president now owns 121,151 shares in the company, valued at approximately $9,091,171.04. This represents a 0.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 38.39% of the company's stock.

Dolby Laboratories Trading Up 2.5%

DLB stock traded up $1.87 during trading hours on Monday, hitting $77.21. 62,101 shares of the stock were exchanged, compared to its average volume of 452,556. Dolby Laboratories, Inc. has a 12 month low of $66.35 and a 12 month high of $89.66. The firm has a market capitalization of $7.37 billion, a P/E ratio of 28.39 and a beta of 0.95. The company has a 50-day simple moving average of $77.07 and a two-hundred day simple moving average of $78.41.

Dolby Laboratories (NYSE:DLB - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The electronics maker reported $1.34 earnings per share for the quarter, beating analysts' consensus estimates of $1.29 by $0.05. Dolby Laboratories had a net margin of 19.97% and a return on equity of 11.32%. The company had revenue of $369.56 million during the quarter, compared to the consensus estimate of $375.44 million. During the same period in the previous year, the business earned $1.27 earnings per share. The firm's quarterly revenue was up 1.4% on a year-over-year basis. On average, equities research analysts predict that Dolby Laboratories, Inc. will post 2.94 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 21st. Shareholders of record on Tuesday, May 13th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.71%. The ex-dividend date is Tuesday, May 13th. Dolby Laboratories's dividend payout ratio is presently 49.81%.

Wall Street Analyst Weigh In

DLB has been the subject of a number of research reports. Rosenblatt Securities cut their target price on shares of Dolby Laboratories from $100.00 to $95.00 and set a "buy" rating for the company in a research note on Friday, May 2nd. StockNews.com downgraded shares of Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a research report on Friday, January 31st. Finally, Barrington Research restated an "outperform" rating and set a $100.00 price objective on shares of Dolby Laboratories in a report on Friday, May 2nd.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.